These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24034596)

  • 21. Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma.
    Jung N; Won JK; Kim BH; Suh KS; Jang JJ; Kang GH
    J Korean Med Sci; 2012 Jun; 27(6):594-604. PubMed ID: 22690089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
    Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
    J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma.
    Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Hishida M; Suenaga M; Yamada S; Inokawa Y; Nishikawa Y; Asai M; Fujii T; Sugimoto H; Kodera Y
    Int J Oncol; 2014 Jan; 44(1):44-52. PubMed ID: 24189587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter aberrant methylation status of
    Chen G; Fan X; Li Y; He L; Wang S; Dai Y; Bin C; Zhou D; Lin H
    Epigenetics; 2020; 15(6-7):684-701. PubMed ID: 31933413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
    Liu T; Chen J; Xiao S; Lei X
    Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation of the ataxia telangiectasia mutated gene (ATM) promoter as a radiotherapy outcome biomarker in patients with hepatocellular carcinoma.
    Yan X; Wu T; Tang M; Chen D; Huang M; Zhou S; Zhang H; Yang X; Li G
    Medicine (Baltimore); 2020 Jan; 99(4):e18823. PubMed ID: 31977876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypermethylation of Ras association domain family protein 1A, hypermethylated in cancer 1 and p73 genes in hepatocellular carcinoma].
    Zhao ZH; Geng XP; Zhu LX; Li HM; Liew CT
    Zhonghua Wai Ke Za Zhi; 2005 Dec; 43(23):1528-32. PubMed ID: 16412291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
    Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of MT1E as a novel tumor suppressor in hepatocellular carcinoma.
    Liu Q; Lu F; Chen Z
    Pathol Res Pract; 2020 Nov; 216(11):153213. PubMed ID: 32956919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
    Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
    BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array.
    Okamura Y; Nomoto S; Kanda M; Li Q; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
    Cancer Lett; 2010 Mar; 289(2):170-7. PubMed ID: 19733004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that is independent of gene methylation.
    Huang L; Li MX; Wang L; Li BK; Chen GH; He LR; Xu L; Yuan YF
    Tumour Biol; 2011 Feb; 32(1):233-40. PubMed ID: 21052890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic and prognostic values of apolipoprotein D alterations in hepatocellular carcinoma.
    Utsunomiya T; Ogawa K; Yoshinaga K; Ohta M; Yamashita K; Mimori K; Inoue H; Ezaki T; Yoshikawa Y; Mori M
    Int J Cancer; 2005 Aug; 116(1):105-9. PubMed ID: 15756681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent methylation of HOXA9 gene in tumor tissues and plasma samples from human hepatocellular carcinomas.
    Kuo CC; Lin CY; Shih YL; Hsieh CB; Lin PY; Guan SB; Hsieh MS; Lai HC; Chen CJ; Lin YW
    Clin Chem Lab Med; 2014 Aug; 52(8):1235-45. PubMed ID: 24681432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. XAF1 is frequently methylated in human esophageal cancer.
    Chen XY; He QY; Guo MZ
    World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of Janus kinase 2 in background normal liver tissue of resected hepatocellular carcinoma is associated with worse prognosis.
    Sonohara F; Nomoto S; Inokawa Y; Hishida M; Takano N; Kanda M; Nishikawa Y; Fujii T; Koike M; Sugimoto H; Kodera Y
    Oncol Rep; 2015 Feb; 33(2):767-73. PubMed ID: 25420511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.